Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type
Keywords: adjuvant therapy; imiquimod; inflammatory response; lentigo maligna; lentigo maligna melanoma; melanoma; melanoma in situ; primary therapyAAD, American Academy of Dermatology; LM, lentigo maligna; LMM, lentigo maligna melanoma; MIS, melanoma in situ; NCCN